title: [Infectious and metabolic nervous system complications of systemic cancer].
abstract: OBJECTIVE
  To review the incidence and causes of the infections and metabolic diseases of the nervous system in patients with systemic neoplasias.
  
  
  METHODS
  Patients with immunodeficiency, particularly those with hematological neoplasias and persons treated with immunosuppressive drugs have a considerable tendency to infection due to opportunist germs. Infections of the nervous system are relatively rare (0.02%-1%) and the commonest neoplasms are lymphomas, especially those of Hodgkin type and lymphosarcomas. The most frequent infections are caused by the herpes virus, meningitis due to Listeria monocytogenes and the meningitis due to fungi (Aspergillus, Candida and Cryptococcus). Cerebral abscesses, although rarer, are relatively common and are caused by gram negative bacteria, fungi and toxoplasmosis. In recent years there has been a notable increase in the number of patients diagnosed as having progressive multifocal leukoencephalopathy due to the possibility of carrying out studies to detect the DNA of the JC virus by polymerase chain reaction techniques. Empirical treatment of patients with neurological infections and systemic cancer should be started following the guidelines for immunodepressed patients. The metabolic complications of these patients are mainly due to hormone overproduction, hydroelectrolytic changes and vitamin deficits, which in general cause alterations of mental function of the confusion state type.
  
  
  CONCLUSIONS
  In all patients with an infection or metabolic complication involving the nervous system, the presence of a systemic neoplasm makes it necessary to vary both the diagnostic approach and the empirical therapeutic measures taken.
authors.affiliation: Sección de Neurología, Hospital Universitari Sant Joan, Reus, Tarragona, España. nortizc@galenics.com
authors.forename: N
authors.initials: N
authors.lastname: Ortiz
mesh_terms: D000208:Acute Disease; D000970:Antineoplastic Agents / Q000009:adverse effects; D001361:Avitaminosis / Q000150:complications; D001922:Brain Abscess / Q000209:etiology; D002908:Chronic Disease; D004198:Disease Susceptibility; D004660:Encephalitis / Q000209:etiology; D004700:Endocrine System Diseases / Q000150:complications; D006562:Herpes Zoster / Q000209:etiology; D006801:Humans; D016867:Immunocompromised Host; D007165:Immunosuppression Therapy / Q000009:adverse effects; D007968:Leukoencephalopathy, Progressive Multifocal / Q000209:etiology; D016920:Meningitis, Bacterial / Q000209:etiology; D016921:Meningitis, Fungal / Q000209:etiology; D009091:Mucormycosis / Q000209:etiology; D009102:Multiple Organ Failure / Q000150:complications; D009220:Myositis / Q000209:etiology; D009369:Neoplasms / Q000150:complications*; D009422:Nervous System Diseases / Q000209:etiology*; D009503:Neutropenia / Q000139:chemically induced / Q000150:complications; D010257:Paraneoplastic Syndromes / Q000209:etiology*; D014883:Water-Electrolyte Imbalance / Q000150:complications
chemical_list: D000970:Antineoplastic Agents
vernacular_title: Complicaciones infecciosas y metabólicas del sistema nervioso debidas a cáncer sistémico.